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Abstract-A new quantitative method was developed for separation of three interactive 
physiological factors (hepatic glucose balance, peripheral tissue’s insulin resistivity and 
insulin secretion rate) influencing glucose intolerance in diabetic mellitus using an equiv- 
alent circuit model and the intravenous glucose tolerance test (IVGTT) in six dogs and 
20 humans. The results show that the estimated model parameters of the above three 
factors are useful for evaluating different glucose-insulin kinetics in normal and diabetic 
subjects. 
I. INTRODUCTION 
The three major physiological factors influencing glucose intolerance in diabetics are 
known as the hepatic glucose balance, the peripheral tissue’s insulin resistivity (inverse 
of sensitivity) and the beta-cell insulin secretion rate. Since these factors are complicatedly 
related and interactive each other, it is difficult to evaluate individually the changes of 
these physiological factors for normal and diabetic subjects. 
In the present paper, we have used an equivalent circuit model for the estimation of 
the peripheral tissue’s insulin resistivity and the hepatic glucose sensitivity in normal and 
diabetic subjects. We have also obtained the fractional hepatic extraction ratio of insulin 
(FHER-I) and the secretion rate of insulin (SR-I) using C-peptide data[l, 21. 
II. EXPERIMENTS AND ANALYSIS 
II. 1. Animal experiments 
Three normal and three diabetic dogs were used for the study. Diabetic condition was 
produced by Alloxan injection 2 days before experiments and was checked by IVGTT 
results. 
After 12 h of overnight fasting, IVGTT experiments were performed. Before the in- 
jection of glucose, radio-opaque catheters were inserted into the hepatic vein and the 
portal vein through incision. After 1 or 2 h of recovery periods. glucose was injected 
intravenously for 2 min (250 mg/min/kg). Venous blood samples were obtained through 
the contralateral vein. Arterial blood samples were obtained through a femoral artery. 
Hepatic and portal venous blood samples were collected through the radio-opaque cath- 
eters. The positions of the catheters were checked by angiography. 
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Whole blood glucose concentrations were immediately measured by YSI glucose Ana- 
lyzer. The plasma insulin concentrations were determined using the double antibody radio- 
immunoassay technique. Hepatic blood flow was estimated at IO-min intervals by the 
clearance and extraction method of Bradley et al. using 113’ labeled rosebengal as the 
extractable materials. 
11.2. Clinical experiments 
Twenty subjects were classified to the normal and diabetic group based on National 
Diabetes Data Group’s Criteria[lj]. Diabetic groups was divided to the moderate and 
severe diabetic group by their fasting blood glucose levels. Severe diabetic subjects had 
fasting blood glucose concentrations above I80 mg/dl. And all of the diabetic patients 
were type II. They were studied after 12 h of overnight fasting. After intravenous injection 
of 25 g (50%, 50 ml) of glucose through an antecubital vein, the blood samples were 
obtained through the contralateral antecubitel vein. 
In addition to the measurements of the whole blood glucose concentrations and the 
plasma insulin concentrations as described above, the plasma C-peptide concentrations 
were also determined using the double antibody radioimmunoassay technique. 
11.3. Equivalent circuit model 
Figure 1 shows the equivalent circuit model for the simulation of the changes of the 
glucose concentrations during IVGTT. In the model, the compartmental volumes are 
represented by electrical capacitances (Ci), and the net rate constants are represented by 
electrical resistances (Ri). 
The equivalent circuit model includes most of the known physiological factors effective 
within I h after glucose loading in IVGTT. G is the exogenous glucose loading. The tissue 
uptake is represented by the current flowing through the time varying resistance, R,, 
where R, is directly related to the insulin resistivity parameter (K,) and inversely related 
to the instantaneous insulin concentration in the slow pool of insulin kinetics model[j- 
61. B is the glucose uptake at the brain, which is independent of glucose and insulin 
concentrations.[7] H is the hepatic glucose balance (uptake or output), represented by 
the equation of H = Ho + H,( Vz - Vzo), where HI is the hepatic glucose sensitivity 
parameter relating the changes of hepatic balance to the changes of the glucose concen- 
trations from the basal level, (V2 - Vto). When H is negative (uptake state), the circuit 
branch location is changed from a - a’ to b - b’[8, 91. The renal glucose excretion rate 
occurring in hyperglycemia is represented by the current through the branch of a diode 
(D)[lO]. The details of the model can be found in our previous paper[lll. 
a b 
a’ b’ 
Fig. I. Equivalent circuit model. 
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11.4. Computer simulation 
Three parameters (capillary-venous blood volume, Cz, hepatic glucose sensitivity, Hi, 
and insulin resistivity, K,) were varied iteratively to provide the condition of the least 
squared error difference between the computed and the measured data. 
For other physiological parameters of the model, we used the following reported values. 
In human’s case, total blood volume is 75.6 ml/kg, slow pool volume (C,) is 100 ml/kg, 
B is 1.08 mg/min/kg, the net hepatic glucose output at basal level (Ho) is 2 mg/min/kg, 
the renal excretion threshold (V,) is 220 mg/dl and the net rate constants RI, RZ and R3 
are 0.026, 0.24 and 0.79, respectively. In dog’s case, B is 2.1 mg/min/kg and Ho is 2.8 mg/ 
minlkg. 
III. RESULTS 
Figure 2 shows the measured average values of the blood glucose and the plasma insulin 
concentrations during IVGTT for normal and diabetic dogs. It is shown that the changes 
of the glucose concentrations were closely simulated by the model. Insulin response in 
normal dogs shows an unusual rises between 40 and 60 min. These may be caused by 
surgical stress. In fact, the dog experiments were performed with continuous stress on 
the subjects. We think, therefore, that stress might cause the glucose level to be maintained 
somewhat higher. And that may be the main reason of the unusual insulin response in 
the normal dog experiments. 
Figure 3 shows the changes of the hepatic glucose balance and the tissue uptake rate 
after glucose loading. Figure 3 shows a good agreement of the hepatic glucose balance 
between the computed results and the measured hepatic balance data obtained from ar- 
terial, portal venous and hepatic venous blood glucose concentration in normal and di- 
abetics. The changes of the hepatic glucose balance and the tissue uptake rate after glucose 
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Fig. 2. Dog experiment data of glucose and insulin concentrations during IVGTT. For the glucose concentration 
curves, the measured data are represented by *, where * shows the mean values and I shows one standard error 
of mean values. The simulation results are represented by the solid line. 
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Fig. 3. Dog experiment data for the estimated changes of the hepatic glucose balance and the tissue uptake 
during IVGTT. The experimental data are shown by * mark. The positive values are for glucose output. and 
the negative values are for glucose uptake. 
loading are shown to be negligible in diabetics, as compared with significant changes in 
normal dogs. 
Figure 4 shows the measured changes of the blood glucose, plasma insulin and plasma 
C-peptide concentrations after glucose loading for normal and diabetic subjects in clinical 
experiments. In this clinical case, also, the change of the glucose concentrations were 
closely simulated by the model. Figure 5 shows the hepatic glucose balance v.ith the tissue 
uptake rate during IVGTT in humans. Similarly to the animal experiment results, there 
is considerable differences in the hepatic glucose balance and the tissue uptake between 
normal and diabetic patients. 
Tables 1 and 2 summarize the best fitted data of the capillary-venous blood volume 
(CZ), the hepatic glucose sensitivity (Hi), the peripheral tissue’s insulin resistivity (K,), 
the insulin secretion rate (SR-I) and the fractional hepatic extraction ratio of insulin 
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Fig. 4. Human experiment data of the glucose, insulin and C-peptide concentrations during IVGTT. For the 
glucose concentration curves, the clinical data are represented by *, where * shows the mean values, and I 
shows one standard error of mean values. And the simulation results are represented by the solid line. 
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Fig. 5. Human experiment data for the estimated changes of the hepatic _elucose balance and the tissue uptake 
during IVGTT. The positive values are for glucose output, and the negative values are for gl;lcose uptake. 
(FHER-I) for normal and diabetic dogs and three clinical groups. Table 3 shows the 
individual data of human experiments. 
The goodness-of-fit was represented by the ratio v%%@, where EM’ is the mean of 
squared errors of the individual glucose measurement. Errors of glucose measurements 
were assumed to be 3% of the mean values. 
Table I. Dog experiment data for the estimated values 
of C2 (ml/kg), H, and K, (mean = SEW. E’ is the 
residual mean square 
Group 
Parameters Normal (3) Diabetics (3) P-value 
c2 111.1 + 14.7 94.5 i- 27.7 0.2 
HI -1.1 ? 0.1 0 0.05 
K 36.1 -c 4.5 94.3 + 5.9 0.025 
E2 0.73 1.04 
Table 2. Human experiment data for the estimated value of C’ (ml/kg), 
HI, K,, SR-I (ng/min) and FHER-I (mean z SEM). E’ is the residual 
mean square. P-values are normal vs diabetics (moderate T severe) 
Group 
Parameters Normal (9) 
Moderate 
diabetic (5) 
Severe 
diabetics (6) P-value 
c2 151.7 I 9.4 160.5 I 18. 132.5 2 17.7 0.1 
HI - 1.9 I 0.2 -0.9 -c 0.2 0 0.05 
K, 18.5 = 2.0 31.8 -c 5.1 56.6 2 11.6 0.05 
SR-I 1823.9 + 155 1569.1 2 332 1385 + 291 0.1 
FHER-I 0.55 I 0.03 OS5 2 0.08 0.54 I 0.08 N.S. 
E? 0.56 0.52 0.48 
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Table 3(a). Estimated values of V2 (ml/kg), HI and K, for the normal subjects 
Subject Sex Age 
Fasting levels Simulation results 
% of ideal Glucose Insulin 
body weight (rn&il) (b&ml) VZ HI K, Gf3E.W 
B.J. 
KS. 
I.K. 
H.C. 
W.S. 
M.D. 
D.H. 
M.K. 
J.W. 
mean 
? S.D. 
M 49 
M 53 
: 28 35
!z 31 
38 
M 40 
: 43 
53 
41.1 
18.6 
84 75 5.1 
88.7 85 2.1 
88 62 5.7 
98.5 86 7.2 
87.5 73 I.0 
91.2 62 1.2 
92.1 80 3.0 
95.4 77 3.6 
94 99 7.8 
91.0 77.7 4.1 
24.2 211.1 -_. +7 3 
125 
153.3 
179.2 
120.8 
142.7 
201 
118.8 
192.7 
132.2 
151.7 
+ 29.9 
- 1.4 
-2.0 
-2.8 
-0.83 
-2.2 
- 1.03 
-2.44 
-2.1 
- I .a2 
- I .a5 
20.61 
18 0.96 
13 2.10 
a 2. I7 
19.4 I .46 
13.7 I .42 
23.85 2.01 
17.75 I .50 
28.75 2.13 
19.5 
18.0 
25.75 
“I _.- 
1.77 
c 0.42 
Table 3(b). Estimated values of VI (ml/kg), HI and K, for the moderate diabetic subjects 
Subject Sex Age 
Fasting levels Simulation results 
% of ideal Glucose Insulin 
body weight (mg/dlI (pmml) V1 H: K, e 
J.S. M 56 10j.j 125 9.8 183.3 -0.01 37 0.48 
S.M. : 43 105.3 118 a.7 140 -0.5 26 I.57 
H.S. 50 98.6 179 4.6 155.2 - 1.0 IS.5 1.03 
S.L. M 44 92.3 155 21.5 239.5 -2.45 21.5 2.17 
M.P. M 42 96.9 126 4.5 117.5 -1.35 20.4 1.95 
Mean 47 99.1 140.6 9.8 167.1 - I .06 23.5 1.44 
+ S.D. 25.3 -cS.l 223.0 ~6.2 242.0 20.8 28.0 ~0.61 
Table 3(c). Estimated values of V, (ml/kg), HI and K, for the severe diabetic subjects 
Subject Sex Age 
Fasting levels Simulation results 
% of ideal Glucose Insulin 
body weight Cmg/dl) bnhl) VZ HI KC l/FEZ 
D.Y. M 54 97 181 9.7 140 0 33.1 0.89 
T.K. M 37 90 231 5.5 163.7 - 1.94 34.5 0.69 
T.S. M 45 89.2 296 11 90 0 100 0.27 
S.M. M 44 101.5 210 16.7 90 0 100 1.84 
J.Y. M 60 81.8 256 18.3 191.7 -0.93 26.9 0.52 
NM. M 42 109.5 204 19.5 179.2 0 55 1.37 
mean 47 94.8 229.6 13.5 142.4 -0.47 56.5 0.93 
t S.D. k7.7 29.0 5 37.7 55.1 240.3 f 0.73 -32.6 2 :O.lZ 
All computations and simulations were carried out using a Digital Equipment Corpo- 
ration MINC-11 computer. 
IV. DISCUSSION 
In this paper we present a new quantitative method of estimating the peripheral tissue’s 
insulin resistivity and the hepatic glucose sensitivity from the measured IVGTT data and 
the equivalent circuit model. It is shown in evaluation of our model that the changes of 
model-based sensitivity parameters between clinical groups agree with other clinical ob- 
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servations[l3. 141. For example, the diminution of the sensitivity parameters becomes 
greater together with severity of diabetic condition. Also, the estimated hepatic balance 
in diabetic subjects agrees with the clinical observation[l3], where the hepatic output in 
diabetics was shown to be not suppressed even with a rapid increase of glucose concen- 
tration after glucose loading. In other experimental study[l4], the amount of the hepatic 
glucose balance was shown to have almost comparable magnitude as the glucose uptake 
amount at tissue sites, which is similar to our present estimated results. 
In conclusion, the results show that the IVGTT data and the equivalent circuit model 
can provide a quantitative method for separation of the effects of the peripheral tissue’s 
glucose uptake rate, the hepatic glucose balance and the insulin secretion rate. It is also 
shown that these factors are useful in evaluating different glucose-insulin dynamics for 
clinical groups of normal and diabetic subjects. 
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